Health Care/Hospital
Health supplement information app Pillwork set for launch in the first-half year
SEOUL, South Korea, Jan. 17, 2023 /PRNewswire/ -- Pillwork releases its app
Pillwork that allows people to easily compare and purchase health supplements
in the first-half year.
2023-01-17 15:03
1436
OPHTECS Global Team Welcomes Dr. Schnider, One of Most Influential Women in Optical Industry and One of World's Most Prominent Contact Lens Researchers and Educators
- Enforcing Company's R&D Efforts for New Lens Care Products and Global Professional Relation Activities - KOBE, Japan, Jan. 17, 2023 /PRNewswire/ -- OPHTECS Corporation (hereinafter referred to as OPHTECS), aKobe-based company which researches, develops, produces and markets contact lens care p...
2023-01-17 14:00
1849
Organon Is Recognized as Both "Top Employers China 2023" And "Best Workplaces™ in Greater China 2022"
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Today, Organon China is proud to have been named the "2023 Top Employers inChina" and honored to receive "Best Workplaces™ inGreater China 2022" certificate, in recognizing its vision-driven company culture, diversity and inclusion, strong employer brand, a...
2023-01-17 13:06
1497
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments ofSteffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO). Dr. Heeger has held senior oncology clinical developme...
2023-01-17 10:00
1760
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere
HANGZHOU and SHAOXING, China, Jan. 17, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply agreement of ritonavir tablets with Hainan Simcere Pharmaceutical Co., Ltd., a su...
2023-01-17 08:29
2305
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China
Affamed to obtain sole commercialization rights upon regulatory approval in Mainland China to Galcanezumab, a monoclonal antibody that selectively binds to calcitonin gene-related peptide (CGRP). Target to address unmet medical needs for millions of Chinese migraine patients. SHANGHAI, Jan. 17, ...
2023-01-17 08:00
4682
FDA Accepts GMP Plasmid DMF of OBiO Technology
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administ...
2023-01-17 08:00
1904
Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery
HONG KONG, Jan. 17, 2023 /PRNewswire/ -- Agilis RoboticsTM (Agilis), a leading developer of flexible robotic instruments that support endoscopic surgery through natural orifices of the body (e.g. along the gastrointestinal tract and in the bladder), has recently completed the second round of live...
2023-01-17 08:00
2917
AMCOR EXPANDS HEALTHCARE PLATFORM IN THE ASIA PACIFIC REGION WITH ACQUISITION OF MDK
Complementary capabilities, product offering, and customer base solidifies leadership position in priority high growth medical device packaging segment ZURICH, Jan. 16, 2023 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, ...
2023-01-17 06:00
2908
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference
SHENZHEN, China, Jan. 16, 2023 /PRNewswire/ -- FAPON, a leading life sciences company, announced that Mr. Jielun ZHU, the company's Chief Financial Officer (CFO) and Chief Investment Officer (CIO), has presented at the 41st Annual J.P. Morgan Healthcare Conference and shared FAPON's development, ...
2023-01-16 22:09
2703
Fiberstar, Inc. Launches New Organic Citrus Fibers for Food & Beverages
RIVER FALLS, Wis., Jan. 16, 2023 /PRNewswire/ -- Fiberstar, Inc., the leader of innovative citrus fibers launched a line of new organic citrus fibers – Citri-Fi ® 400 series. These new citrus fibers are in response to the increasing demand for natural, sustainable and organic food ingredients. Mar...
2023-01-16 22:05
2572
ESAOTE S.p.A. gets on board with "The Ocean Race: Genova, the Grand Finale".
GENOA, Italy, Jan. 16, 2023 /PRNewswire/ -- Esaote, a leading company in the biomedical sector – in ultrasound, dedicated magnetic resonance imaging and Information Technology for healthcare– is Supporter of "The Ocean Race: Genova, the Grand Finale". As such, it will be taking part in the Round ...
2023-01-16 20:00
8815
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, andHuadong Medicine ( Hangzhou) Co., Ltd., a wholly-owned subsidiary of Huadong Medicine Co....
2023-01-16 18:00
2172
Medtech Innovator magAssist Inc. Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum
SUZHOU, China, Jan. 16, 2023 /PRNewswire/ -- magAssist Inc. ("magAssist"), a leading global developer of extracorporeal life support devices, attended the 2022 Critical Heart Disease Congress - International Society for Mechanical Circulatory Support Parallel Forum, where the firm shared the late...
2023-01-16 17:25
3062
Identity for All Children and their Brighter Future in an Accessible Society for All
By utilizing biometrics, developing countries can effectively work with their citizens for wide-scale enrollment and expanded public service delivery SAN ANTONIO, Jan. 16, 2023 /PRNewswire/ -- The United Nations (UN) expressed its aim to "provide legal identity to all, including birth registratio...
2023-01-16 16:12
1690
MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe
SHENZHEN, China, Jan. 16, 2023 /PRNewswire/ -- Thanks to initiatives such as the 1+ Million Genomes, world-class academic and public research funding, as well as extensive regulatory and clinical applications,Europe has become a top genomics market and technology leader. With a commitment to buil...
2023-01-16 12:00
2184
Ascletis Announces Dosing of 4 Healthy Subjects of the First Cohort in Multiple-Dose Escalation Phase I Clinical Trial of Oral 3CLpro Inhibitor ASC11 for COVID-19
--The multiple-dose escalation Phase I clinical trial is expected to enroll 72 healthy subjects, and the enrollment is expected to be completed in the first quarter of 2023 --Ascletis has filed global patent applications for ASC11 and related compounds and their use in viral disease HANGZHOU an...
2023-01-16 08:10
2540
Forever Living Products International Announces New President
Former Executive Vice President of Sales Aidan O'Hare takes on new role, while former PresidentGregg Maughan continues his role as Chief Executive Officer SCOTTSDALE, Ariz., Jan. 16, 2023 /PRNewswire/ -- Forever Living Products International, a direct sales health and beauty company with presenc...
2023-01-16 08:05
2370
CGTN: China protects lives, shares experience in global COVID-19 fight
BEIJING, Jan. 16, 2023 /PRNewswire/ -- Chinese people are embracing a bustling winter after the country downgraded its COVID-19 management policies. It's a breakthrough in the country's three-year fight against the pandemic, but challenges still lie ahead. Along the journey, China went all out...
2023-01-16 07:29
2116
Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board
SHANGHAI, Jan. 14, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced the appointment of Dr.Mingdong Zhang to the company's Scientific Advisory Board (SAB). Dr. Zhang will provide guidance on Pulnovo Medical's clinical development and registration strategy...
2023-01-14 22:00
3470
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 251 media titles]
2024-04-30 15:13Most Read
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2946
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2943
